Alps Advisors Inc Arcturus Therapeutics Holdings Inc. Transaction History

Alps Advisors Inc

  • $17.2 Billion
  • Q2 2025

A detailed history of Alps Advisors Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 14,619 shares of ARCT stock, worth $329,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,619
Previous 19,949 26.72%
Holding current value
$329,804
Previous $211,000 9.95%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$8.91 - $14.41 $47,490 - $76,805
-5,330 Reduced 26.72%
14,619 $190,000
Q1 2025

Apr 30, 2025
SELL
$10.59 - $20.83 $20,671 - $40,660
-1,952 Reduced 8.91%
19,949 $211,000
Q4 2024

Feb 13, 2025
BUY
$14.82 - $25.48 $933 - $1,605
63 Added 0.29%
21,901 $371,000
Q3 2024

Nov 12, 2024
SELL
$18.08 - $25.38 $149,648 - $210,070
-8,277 Reduced 27.48%
21,838 $506,000
Q2 2024

Aug 13, 2024
BUY
$24.35 - $44.39 $51,183 - $93,307
2,102 Added 7.5%
30,115 $733,000
Q1 2024

May 14, 2024
SELL
$31.23 - $42.99 $6,464 - $8,898
-207 Reduced 0.73%
28,013 $945,000
Q4 2023

Feb 14, 2024
SELL
$17.71 - $32.97 $37,244 - $69,335
-2,103 Reduced 6.94%
28,220 $889,000
Q3 2023

Nov 14, 2023
BUY
$25.44 - $37.35 $274,726 - $403,342
10,799 Added 55.31%
30,323 $774,000
Q2 2023

Aug 14, 2023
BUY
$23.94 - $32.36 $467,404 - $631,796
19,524 New
19,524 $559,000
Q3 2022

Nov 14, 2022
SELL
$13.05 - $22.13 $15,607 - $26,467
-1,196 Reduced 7.63%
14,481 $215,000
Q2 2022

Aug 11, 2022
SELL
$12.26 - $31.17 $140,070 - $356,117
-11,425 Reduced 42.16%
15,677 $247,000
Q1 2022

May 16, 2022
SELL
$17.64 - $39.57 $60,028 - $134,656
-3,403 Reduced 11.16%
27,102 $731,000
Q4 2021

Feb 09, 2022
SELL
$34.2 - $47.56 $59,986 - $83,420
-1,754 Reduced 5.44%
30,505 $1.13 Million
Q3 2021

Nov 15, 2021
SELL
$27.88 - $58.25 $67,079 - $140,149
-2,406 Reduced 6.94%
32,259 $1.54 Million
Q2 2021

Aug 11, 2021
BUY
$25.79 - $42.11 $894,010 - $1.46 Million
34,665 New
34,665 $1.17 Million
Q4 2020

Feb 03, 2021
SELL
$34.61 - $123.66 $1.08 Million - $3.85 Million
-31,101 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$37.49 - $63.19 $118,018 - $198,922
3,148 Added 11.26%
31,101 $1.33 Million
Q2 2020

Aug 05, 2020
BUY
$12.66 - $58.27 $353,884 - $1.63 Million
27,953 New
27,953 $1.31 Million

Others Institutions Holding ARCT

# of Institutions
171
Shares Held
25.9M
Call Options Held
321K
Put Options Held
136K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $600M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email